Publication: 227

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 27 (27) 4487-4491
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
630  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, CA33601, CA47577, U10 CA045564, CA41287, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA045389, CA45389, CA45808, U10 CA041287, CA45564, CA31946  
Corr. Author:
 
Authors:
             
Networks:
 
Study
CALGB-30402
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Thor5, Original Reports, Thoracic Oncology